Inventor
BAECKSTROEM REIJO
FI16 patents
⚠️ This page may combine multiple inventors who share the name “BAECKSTROEM REIJO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORION YHTYMAE OY
9 patentsUS5569657AOct 29, 1996
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
ORION YHTYMAE OY48 citations93
US5112861AMay 12, 1992
Method of treating parkinson's disease using pentanedione derivatives
ORION YHTYMAE OY48 citations91
US5614541AMar 25, 1997
Pharmacologically active catechol derivatives
ORION YHTYMAE OY13 citations80
US5424428AJun 13, 1995
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
ORION YHTYMAE OY15 citations79
US6121303ASep 19, 2000
Pharmacologically active catechol derivatives
ORION YHTYMAE OY7 citations71
US5889037AMar 30, 1999
Pharmacologically active catechol derivatives
ORION YHTYMAE OY8 citations71
US5512571AApr 30, 1996
(-) 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl!-hydra-zono!propanedinitrile
ORION YHTYMAE OY8 citations71
US5362733ANov 8, 1994
Pharmacologically active catechol derivatives
ORION YHTYMAE OY11 citations71
US5356923AOct 18, 1994
1-hydroxy-4(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone and anti-hypertensive use thereof
ORION YHTYMAE OY0 citations42
ORION CORP
6 patentsUS6903114B2Jun 7, 2005
Derivatives of naphthalene with COMT inhibiting activity
ORION CORP37 citations89
US6730673B1May 4, 2004
Pharmaceutical solutions of levosimendan
ORION CORP10 citations65
US6180789B1Jan 30, 2001
Method for obtaining pure enantiomers of a pyridazinone derivative
ORION CORP9 citations63
US6340764B1Jan 22, 2002
Reference compound for use in the analysis of levosimendan batches
ORION CORP3 citations52
US6943164B2Sep 13, 2005
Pharmaceutical solutions of levosimendan
ORION CORP0 citations44
US6699868B2Mar 2, 2004
Pyridazinyl phenyl hydrazones useful against congestive heart failure
ORION CORP0 citations38